NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 45 filers reported holding NEUROCRINE BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,373,197 | +572.8% | 14,351,000 | +474.0% | 0.02% | +633.3% |
| Q2 2023 | $3,176,523 | -5.9% | 2,500,000 | 0.0% | 0.00% | -25.0% |
| Q1 2023 | $3,376,802 | -14.9% | 2,500,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $3,970,192 | +12.2% | 2,500,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $3,540,000 | +7.0% | 2,500,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $3,308,000 | -93.5% | 2,500,000 | -93.5% | 0.00% | -91.7% |
| Q1 2022 | $50,796,000 | +4.8% | 38,635,000 | 0.0% | 0.05% | +20.0% |
| Q4 2021 | $48,457,000 | -6.1% | 38,635,000 | 0.0% | 0.04% | -14.9% |
| Q3 2021 | $51,580,000 | -0.9% | 38,635,000 | -1.6% | 0.05% | +4.4% |
| Q2 2021 | $52,046,000 | +667.0% | 39,270,000 | +685.4% | 0.04% | +542.9% |
| Q1 2021 | $6,786,000 | -50.8% | 5,000,000 | -50.0% | 0.01% | -50.0% |
| Q3 2020 | $13,805,000 | – | 10,000,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CSS LLC/IL | 15,659,000 | $23,207,687 | 1.52% |
| SONA ASSET MANAGEMENT (US) LLC | 17,500,000 | $26,317,952 | 1.09% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 26,765,000 | $40,113,099 | 0.86% |
| Warberg Asset Management LLC | 1,271,000 | $1,885,846 | 0.38% |
| SSI INVESTMENT MANAGEMENT LLC | 2,296,000 | $3,406,116 | 0.28% |
| Paloma Partners Management Co | 3,125,000 | $4,694,590 | 0.16% |
| FRANKLIN RESOURCES INC | 54,750,000 | $81,769,125 | 0.04% |
| Rock Springs Capital Management LP | 1,000,000 | $1,497,950 | 0.04% |
| LORD, ABBETT & CO. LLC | 4,666,000 | $6,922 | 0.03% |
| D. E. Shaw & Co., Inc. | 14,351,000 | $21,373,197 | 0.02% |